日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

发现并鉴定出新型中肾素抑制剂HBS-101,作为治疗三阴性乳腺癌的治疗药物

Mahajan, Megharani; Rodriguez Sanchez, Alondra L; Jayamohan, Sridharan; Vijayan, Dileep K; Johnson, Jessica D; Xie, Huan; Wang, Yang; Liang, Dong; Sanchez, John R 2nd; Subbarayalu, Panneerdoss; Rao, Manjeet K; Vadlamudi, Ratna K; Sareddy, Gangadhara R; Nair, Hareesh B; Viswanadhapalli, Suryavathi

KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.

KDM1A/LSD1抑制剂可增强卵巢癌的化疗反应

Chen Yihong, Johnson Jessica D, Jayamohan Sridharan, He Yi, Venkata Prabhakar P, Jamwal Diksha, Alejo Salvador, Zou Yi, Lai Zhao, Viswanadhapalli Suryavathi, Vadlamudi Ratna K, Kost Edward, Sareddy Gangadhara R

Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma

赖氨酸特异性组蛋白去甲基化酶1A (KDM1A/LSD1) 抑制剂可减弱DNA双链断裂修复,并增强替莫唑胺在胶质母细胞瘤中的疗效。

Alejo, Salvador; Palacios, Bridgitte E; Venkata, Prabhakar Pitta; He, Yi; Li, Wenjing; Johnson, Jessica D; Chen, Yihong; Jayamohan, Sridharan; Pratap, Uday P; Clarke, Kyra; Zou, Yi; Lv, Yingli; Weldon, Korri; Viswanadhapalli, Suryavathi; Lai, Zhao; Ye, Zhenqing; Chen, Yidong; Gilbert, Andrea R; Suzuki, Takayoshi; Tekmal, Rajeshwar R; Zhao, Weixing; Zheng, Siyuan; Vadlamudi, Ratna K; Brenner, Andrew J; Sareddy, Gangadhara R

Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study

赖氨酸特异性去甲基化酶 1 作为癌症治疗靶点:来自临床前研究的观察

Johnson, Jessica D; Alejo, Salvador; Jayamohan, Sridharan; Sareddy, Gangadhara R